Compass Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.5M Buy
12,944
+209
+2% +$214K 0.94% 31
2026
Q1
$11.7M Sell
12,735
-458
-3% -$464K 0.71% 33
2025
Q4
$14.2M Sell
13,193
-3,108
-19% -$2.97M 0.79% 28
2025
Q3
$12.4M Sell
16,301
-2,136
-12% -$1.59M 0.66% 35
2025
Q2
$14.4M Buy
18,437
+18,177
+6,991% +$14.1M 0.77% 36
2025
Q1
$215K Hold
260
0.01% 35
2024
Q4
$201K Hold
260
0.01% 37
2024
Q3
$230K Hold
260
0.01% 35
2024
Q2
$235K Hold
260
0.02% 35
2024
Q1
$202K Buy
+260
New +$185K 0.01% 35

Other funds holding LLY

Compass Capital Management's LLY Position: Q2 2026 in Review

Compass Capital Management increased its Eli Lilly (LLY) stake by 1.6% in Q2 2026, buying an estimated $214K and bringing the position to 12,944 shares worth $15.5M. The position accounts for 0.94% of the portfolio, ranked #31.

Compass Capital Management first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Compass Capital Management held 12,944 shares of Eli Lilly worth $15.5M as of Q2 2026.
  • Compass Capital Management bought 209 Eli Lilly shares in Q2 2026, an estimated $214K.
  • Eli Lilly made up 0.94% of Compass Capital Management's portfolio in Q2 2026, its #31 holding.
  • Compass Capital Management first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • 4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Compass Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.